Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002581766 | SCV003487947 | likely benign | not provided | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003138519 | SCV003828183 | uncertain significance | Porencephaly 2 | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004587428 | SCV005076842 | uncertain significance | not specified | 2024-04-09 | criteria provided, single submitter | clinical testing | Variant summary: COL4A2 c.398G>T (p.Gly133Val) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.9e-05 in 219394 control chromosomes (gnomAD). To our knowledge, no occurrence of c.398G>T in individuals affected with Porencephaly 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2173147). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Ambry Genetics | RCV004614358 | SCV005103928 | likely benign | Inborn genetic diseases | 2024-04-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |